Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Company not found

Latest Headlines

Follow companies to personalize your feed

Today
Nexgel IncBusiness
NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
10 minutes ago
Abbott LaboratoriesHealth
New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
10 minutes ago
Zentalis Pharmaceuticals LlcBusiness
Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026
32 minutes ago
Surgery Partners IncBusiness
Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details
32 minutes ago
Zai Lab LtdBusiness
Zai Lab Presents New Data Demonstrating Zocilurtatug Pelitecan (Zoci) Induces Rapid and Robust Intracranial Responses in Small Cell Lung Cancer with Brain Metastases and Promising Activity in Other Neuroendocrine Carcinomas
32 minutes ago
Meiji Holdings Co., Ltd.Health
Meiji Holdings Co., Ltd. Highlights that Yogurt Containing Bacteria Metabolite Shows a Tendency Toward Higher Response When Added to Immune Checkpoint Inhibitor Therapy in People Living with Non-small Cell Lung Cancer
32 minutes ago
Innate PharmaBusiness
Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026
32 minutes ago
Heartbeam IncBusiness
HeartBeam (BEAT) Closes $10M Public Offering to Advance Cardiac Technology Commercialization
33 minutes ago
Immatics NvBusiness
PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma
33 minutes ago
Mink Therapeutics IncBusiness
MiNK Therapeutics Reports Phase II Data on Immune Reprogramming and Durable Survival in PD-1 Refractory Gastroesophageal Cancer
33 minutes ago
Dime Community Bancshares, Inc.Business
Dime to Release Earnings on April 23, 2026
an hour ago
Sun Communities IncBusiness
Sun Communities, Inc. Announces Date for First Quarter 2026 Earnings Release and Conference Call
an hour ago
Pg&e CorpBusiness
PG&E Launches the PG&E PowerHouse -- An All-Electric Home Designed to Make Electrification Easier and More Affordable
an hour ago
Nvent Electric PlcBusiness
nVent Electric plc to Report First Quarter 2026 Financial Results on May 1
2 hours ago
Chino Commercial BancorpBusiness
Chino Commercial Bancorp Reports 24.7% Increase in Net Earnings
2 hours ago
Tesla IncBusiness
For the First Time, Model S and Model X Owners Have a Serious Aftermarket Efficiency Wheel: Unplugged Performance Launches the UP-RW FF
2 hours ago
Kaltura IncBusiness
Kaltura to Showcase Agentic Revenue Engagement Platform at Adobe Summit 2026, Demonstrating How Agentic AI Avatars and Content Intelligence Turn Static ABM Pages Into Real-Time Conversations
3 hours ago
Allied Strategic Resources CorpBusiness
Allied Strategic Resource Announces Name Change
3 hours ago
Huntington Ingalls Industries IncBusiness
HII Introduces Distributed Maritime Operations Framework in Support of U.S. Navy’s “Hedge Strategy”
3 hours ago
S&p Global IncBusiness
The World Will Need More Copper in the Next 30 Years Than It Has Consumed in All of Human History. Ex Pentagon Advisor Says One American Company Controls the Deposit That Could Change Everything.
3 hours ago
Business
10m ago
Less than 1 min read

NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

NEXGEL, INC.

LANGHORNE, Pa., April 17, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it is moving up its shareholder update conference call from Thursday, April 23rd to Tuesday, April 21st, 2026, at 4:30 P.M. ET.

Shareholder Update Call Details:
Date: April 21, 2026
Time: 4:30 P.M. ET
Live Call: 1-800-267-6316 (U.S. Toll Free) or 1-203-518-9783 (International)
Webcast: Events and Presentations

About NEXGEL, Inc.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
[email protected]


DISCLAIMER OF LIABILITY

6ix Inc. ("6ix") licenses software to publicly traded issuers of securities ("Issuers" and each an "Issuer") which can be used by Issuers to communicate with current and prospective investors ("Investors" and each an "Investor") on the online platform maintained by 6ix Inc. at www.6ix.com (the "Platform"). Each Issuer is solely responsible for all content relating to the Issuer on the 6ix Platform, including without limitation all investor summits presented by the Issuer and all summary information about the Issuer on the 6ix Platform.

All content provided on the 6ix Platform is for informational and educational purposes only and should not be construed as investment advice or an offer or solicitation in respect to any products or services. The content presented on the 6ix Platform should not be used as the basis for any investment decision, and does not purport to provide any legal, tax or accounting advice. There are inherent risks involved with investing in Issuers, as set out in the public disclosure record of each Issuer. Issuers are not responsible for revising or updating any information that they present on the 6ix Platform.

Investors should refer to the continuous disclosure documents filed by each Issuer under applicable securities laws, including risk factors and warnings regarding "forward looking information". Issuers are solely responsible for compliance with applicable securities laws, and 6ix makes no representations and provides no assurances to Investors regarding the accuracy or truthfulness of information presented by Issuers on the 6ix Platform or in their public disclosure records.

6ix is not licensed to trade, deal or advise in securities in any jurisdiction. 6ix does not recommend or endorse any Issuer on the 6ix Platform, nor does 6ix verify the accuracy of any information presented by Issuers to Investors on the 6ix Platform or in their public disclosure records. 6ix's sole responsibility as the operator of the 6ix Platform is to provide software to Issuers and Investors through which Issuers and Investors communicate directly with each other without any intermediation or intervention by 6ix other than in respect of technical, logistical or advertising and marketing support. Issuers pay 6ix a licensing fee for use of the 6ix Platform, and 6ix may also receive payment from Issuers to pay for advertising on third-party websites. 6ix and its principals may make and hold investments in securities of Issuers on the 6ix Platform and 6ix may offer reduced rates for its software services to Issuers in which 6ix and/or its principals are invested.

ALL CONTENT ON THE PLATFORM IS PROVIDED BY THE ISSUERS "AS IS" AND "AS AVAILABLE". 6IX DOES NOT GUARANTEE THE ACCURACY OF ITS CONTENT. BY USING THE PLATFORM, EACH INVESTOR AGREES TO ACCEPT ANY RISKS ASSOCIATED WITH THE USE OF THE PLATFORM AND ACKNOWLEDGES THAT 6IX IS NOT RESPONSIBLE FOR ANY CONTENT PRESENTED BY OR RELATING TO ISSUERS ON THE PLATFORM.

6IX DOES NOT WARRANT THAT THE PROVISION OF INFORMATION BY ISSUERS ON THE PLATFORM WILL BE ERROR-FREE, TIMELY, COMPLETE OR ACCURATE. USE OF THE PLATFORM AND RELIANCE THEREON IS AT INVESTOR'S SOLE RISK. 6IX WILL NOT BE IN ANY WAY BE LIABLE TO ANY INVESTOR OR ISSUER OR ANY OTHER ENTITY OR PERSON FOR ANY INACCURACIES, ERRORS, OMISSIONS, DELAYS, DAMAGES, CLAIMS, LIABILITIES OR LOSSES, REGARDLESS OF CAUSE, IN OR ARISING FROM THE USE OF THE PLATFORM.

IN NO EVENT WILL 6IX BE LIABLE FOR ANY DAMAGES, INCLUDING WITHOUT LIMITATION DIRECT OR INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, LOSSES OR EXPENSES ARISING IN CONNECTION WITH THE USE OF THE PLATFORM BY INVESTORS AND/OR ISSUERS EVEN IF 6IX IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, LOSSES OR EXPENSES. FURTHER, 6IX SHALL NOT BE LIABLE IN ANY MANNER FOR THE PRODUCT OR SERVICES OF ANYONE WHO REDISTRIBUTES THE INFORMATION PROVIDED ON THE PLATFORM, AND SUCH REDISTRIBUTION IS EXPRESSLY PROHIBITED.